Biow
1 known investors
BIOW develops solutions targeting the health effects of air pollution exposure, specifically investigating how bioavailable anions may support mitochondrial function and neural resilience in the context of neurodegenerative diseases and aging. The company conducts clinical research on biomarker changes and microbiome effects through advanced proteomics and metabolomics analysis.